Sign in

or Register now

MyDiabetesCentral.com

See all of our health sites at www.HealthCentral.com
Tuesday, November, 24, 2009
  • Font size
Shedding Light on the Co-morbidities of DiabetesThe Complications of Having Rheumatoid Arthritis and Diabetes

Short-Acting Insulin Isn’t Short for Most Type 2s

David Mendosa
David Mendosa
Close
Medical Journalist Living with Diabetes and Author of Fitness and Photography for Fun, www.mendosa.com/fitnessblog

After earning a B.A. with honors from the University of California,...

David Mendosa

Thursday, June 28, 2007
View All of David Mendosa's Posts

“If you inject 10 units of short-acting insulin into obese subjects, there is not much difference in time to peak effect,” he said. “But the time is tripled with triple the dose – the kind of dose an obese person with diabetes is much more likely to need.”

This means that what we generally call rapid-acting insulin isn’t rapid at all. It may take as much as 45 minutes to go to work.

This could explain a lot of the control issues that I’ve seen among type 2s who use Humalog or Novolog. I know obese type 2s who take rapid-acting insulin immediately before eating and then wondered why the insulin didn’t match their food intake.

If you take large doses of one of the rapid-acting insulins and are seeing a mismatch, what can you do now? Certainly a few days of careful testing of your blood glucose levels before and after your meals at half-hour intervals will help. If you find that your glucose and insulin peaks aren’t matching well enough, you can discuss with your physician or diabetes nurse educator about injecting sooner - half an hour to 45 minutes before eating might work better.

(Read David Mendosa's full report from the American Diabetes Association conference here.)
  • Font size
  • Bookmark
  • Thank you for your input
  • Save
  • RSS
  • Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (2364) >